China's Commerce and Science Ministries Propose Revised Export Technology Catalog Covering AI and 40 Other Technologies
nashnova research
China's commerce and science ministries proposed revising the national export-control catalogue, adding 40 technologies across AI, biopharma, and solar PV to the restricted list — a clear signal that Beijing is now playing its own tech-export card.
What does this catalogue actually control?
The revision targets the *Catalogue of Technologies Prohibited or Restricted from Export*, spanning AI, biopharma, and solar PV — 40 technologies in total.
During the revision period, exports of these technologies fall under interim registration requirements. This means → controls take effect before the final list is even published.
In plain terms = China used to be on the receiving end of import bans; now it is flipping the script and restricting its own tech exports.
Which AI technologies are covered — and what is exempt?
The AI category covers 23 technologies, including large language models, AI agents, computing clusters, and information processing — more than half the total list.
Key exemption: technologies already in the public domain via open source or published academic papers are excluded.
This means → the controls target proprietary, unreleased capabilities, not knowledge that has already spread; the impact on the open-source ecosystem is limited.
How are biopharma and solar PV handled differently?
Biopharma covers 5 technologies including cell and gene therapy, small nucleic-acid drugs, and pathogenic microorganisms; licensing deals that do not transfer ownership qualify for automatic approval fast-track procedures.
Solar PV covers 12 technologies — polysilicon manufacturing, wafer fabrication, cell production — and the controls extend to key equipment that embodies the technology.
In plain terms = biopharma gets a "license-only, no ownership transfer" express lane; solar PV is locked down more tightly, equipment included.
How much will this actually change?
The proposal is still at the public-comment stage; final scope, classification criteria, and enforcement intensity remain undecided.
This means → the signal matters more than the constraint — for now. Markets will watch where the final text draws the line between "prohibited" and "restricted."
This reflects a broader shift: in the US-China tech contest, Beijing is moving from defending against import curbs to playing offence with export controls.
市场有风险，内容仅供研究参考，不构成投资建议。